{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:17:53Z","timestamp":1793931473781,"version":"4.8.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["5R01AR075755"],"award-info":[{"award-number":["5R01AR075755"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cornell University Stem Cell Program Cornell University Center for Vertebrate Genomics","id":[{"id":"https:\/\/ror.org\/05bnh6r87","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vitiligo is an autoimmune skin disease caused by cutaneous melanocyte loss. Although phototherapy and T cell suppression therapy have been widely used to induce epidermal re-pigmentation, full pigmentation recovery is rarely achieved due to our poor understanding of the cellular and molecular mechanisms governing this process. Here, we identify unique melanocyte stem cell (McSC) epidermal migration rates between male and female mice, which is due to sexually dimorphic cutaneous inflammatory responses generated by ultra-violet B exposure. Using genetically engineered mouse models, and unbiased bulk and single-cell mRNA sequencing approaches, we determine that manipulating the inflammatory response through cyclooxygenase and its downstream prostaglandin product regulates McSC proliferation and epidermal migration in response to UVB exposure. Furthermore, we demonstrate that a combinational therapy that manipulates both macrophages and T cells (or innate and adaptive immunity) significantly promotes epidermal melanocyte re-population. With these findings, we propose a novel therapeutic strategy for repigmentation in patients with depigmentation conditions such as vitiligo.<\/jats:p>","DOI":"10.1038\/s41467-024-45034-3","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T06:02:48Z","timestamp":1706335368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation"],"prefix":"10.1038","volume":"15","author":[{"given":"Luye","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6153-1898","authenticated-orcid":false,"given":"Dahihm","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6289-8053","authenticated-orcid":false,"given":"Leanne R.","family":"Donahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menansili Abraham","family":"Mejooli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4342-9416","authenticated-orcid":false,"given":"Nozomi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-5377","authenticated-orcid":false,"given":"Andrew C.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,27]]},"reference":[{"key":"45034_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist, C. & Ezzedine, K. Vitiligo: a review. Dermatology 236, 571\u2013592 (2020).","journal-title":"Dermatology"},{"key":"45034_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","volume":"77","author":"M Rodrigues","year":"2017","unstructured":"Rodrigues, M. et al. New discoveries in the pathogenesis and classification of vitiligo. J. Am. Acad. Dermatol. 77, 1\u201313 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"45034_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine, K., Eleftheriadou, V., Whitton, M. & van Geel, N. Vitiligo. Lancet 386, 74\u201384 (2015).","journal-title":"Lancet"},{"key":"45034_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","volume":"22","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine, K. et al. Psychosocial effects of vitiligo: a systematic literature review. Am. J. Clin. Dermatol. 22, 757\u2013774 (2021).","journal-title":"Am. J. Clin. Dermatol."},{"key":"45034_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.det.2016.11.014","volume":"35","author":"M Rashighi","year":"2017","unstructured":"Rashighi, M. & Harris, J. E. Vitiligo pathogenesis and emerging treatments. Dermatol Clin 35, 257\u2013265 (2017).","journal-title":"Dermatol Clin"},{"key":"45034_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","volume":"151","author":"BG Craiglow","year":"2015","unstructured":"Craiglow, B. G. & King, B. A. Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy. JAMA Dermatol. 151, 1110\u20131112 (2015).","journal-title":"JAMA Dermatol."},{"key":"45034_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jaad.2015.09.073","volume":"74","author":"JE Harris","year":"2016","unstructured":"Harris, J. E. et al. Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). J. Am. Acad. Dermatol. 74, 370\u2013371 (2016).","journal-title":"J. Am. Acad. Dermatol."},{"key":"45034_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","volume":"396","author":"D Rosmarin","year":"2020","unstructured":"Rosmarin, D. et al. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet 396, 110\u2013120 (2020).","journal-title":"Lancet"},{"key":"45034_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","volume":"387","author":"D Rosmarin","year":"2022","unstructured":"Rosmarin, D. et al. Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo. N. Engl. J. Med. 387, 1445\u20131455 (2022).","journal-title":"N. Engl. J. Med."},{"key":"45034_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.4103\/0019-5154.57604","volume":"54","author":"R Falabella","year":"2009","unstructured":"Falabella, R. Vitiligo and the melanocyte reservoir. Indian J. Dermatol. 54, 313\u2013318 (2009).","journal-title":"Indian J. Dermatol."},{"key":"45034_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","volume":"12","author":"C Levy","year":"2006","unstructured":"Levy, C., Khaled, M. & Fisher, D. E. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol. Med. 12, 406\u2013414 (2006).","journal-title":"Trends Mol. Med."},{"key":"45034_CR12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/cdd.2014.44","volume":"21","author":"G Denecker","year":"2014","unstructured":"Denecker, G. et al. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression. Cell Death Differ. 21, 1250\u20131261 (2014).","journal-title":"Cell Death Differ."},{"key":"45034_CR13","doi-asserted-by":"publisher","first-page":"e1006636","DOI":"10.1371\/journal.pgen.1006636","volume":"13","author":"HE Seberg","year":"2017","unstructured":"Seberg, H. E. et al. TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF. PLoS Genet. 13, e1006636 (2017).","journal-title":"PLoS Genet."},{"key":"45034_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/nm.3194","volume":"19","author":"WC Chou","year":"2013","unstructured":"Chou, W. C. et al. Direct migration of follicular melanocyte stem cells to the epidermis after wounding or UVB irradiation is dependent on Mc1r signaling. Nat. Med. 19, 924\u2013929 (2013).","journal-title":"Nat. Med."},{"key":"45034_CR15","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1038\/jid.2013.235","volume":"133","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. Wnt\/\u03b2-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. J. Investig. Dermatol. 133, 2753\u20132762 (2013).","journal-title":"J. Investig. Dermatol."},{"key":"45034_CR16","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1101\/gad.340281.120","volume":"34","author":"NR Infarinato","year":"2020","unstructured":"Infarinato, N. R. et al. BMP signaling: at the gate between activated melanocyte stem cells and differentiation. Genes Dev. 34, 1713\u20131734 (2020).","journal-title":"Genes Dev."},{"key":"45034_CR17","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/jid.2013.9","volume":"133","author":"HY Handoko","year":"2013","unstructured":"Handoko, H. Y. et al. UVB-induced melanocyte proliferation in neonatal mice driven by CCR2-independent recruitment of Ly6c(low)MHCII(hi) macrophages. J. Investig. Dermatol. 133, 1803\u20131812 (2013).","journal-title":"J. Investig. Dermatol."},{"key":"45034_CR18","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nature09666","volume":"469","author":"MR Zaidi","year":"2011","unstructured":"Zaidi, M. R. et al. Interferon-\u03b3 links ultraviolet radiation to melanomagenesis in mice. Nature 469, 548\u2013553 (2011).","journal-title":"Nature"},{"key":"45034_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41586-020-1935-3","volume":"577","author":"B Zhang","year":"2020","unstructured":"Zhang, B. et al. Hyperactivation of sympathetic nerves drives depletion of melanocyte stem cells. Nature 577, 676\u2013681 (2020).","journal-title":"Nature"},{"key":"45034_CR20","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.stem.2017.09.001","volume":"21","author":"H Moon","year":"2017","unstructured":"Moon, H. et al. Melanocyte stem cell activation and translocation initiate cutaneous melanoma in response to UV exposure. Cell Stem Cell 21, 665\u2013678.e6 (2017).","journal-title":"Cell Stem Cell"},{"key":"45034_CR21","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris, J. E. et al. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-\u03b3 for autoreactive CD8+ T-cell accumulation in the skin. J. Investig. Dermatol. 132, 1869\u20131876 (2012).","journal-title":"J. Investig. Dermatol."},{"key":"45034_CR22","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1002\/cpim.63","volume":"124","author":"RL Riding","year":"2019","unstructured":"Riding, R. L., Richmond, J. M. & Harris, J. E. Mouse model for human vitiligo. Curr. Protoc. Immunol. 124, e63 (2019).","journal-title":"Curr. Protoc. Immunol."},{"key":"45034_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","volume":"11","author":"D Chen","year":"2022","unstructured":"Chen, D., Xu, Z., Cui, J. & Chen, T. A mouse model of vitiligo based on endogenous auto-reactive CD8\u2009+\u2009T cell targeting skin melanocyte. Cell Regen. 11, 31 (2022).","journal-title":"Cell Regen."},{"key":"45034_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1126\/science.1092436","volume":"303","author":"T Tumbar","year":"2004","unstructured":"Tumbar, T. et al. Defining the epithelial stem cell niche in skin. Science 303, 359\u2013363 (2004).","journal-title":"Science"},{"key":"45034_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1755-148X.2011.00832.x","volume":"24","author":"MR Zaidi","year":"2011","unstructured":"Zaidi, M. R., Hornyak, T. J. & Merlino, G. A genetically engineered mouse model with inducible GFP expression in melanocytes. Pigment Cell Melanoma Res. 24, 393\u2013394 (2011).","journal-title":"Pigment Cell Melanoma Res."},{"key":"45034_CR26","doi-asserted-by":"publisher","first-page":"12222","DOI":"10.3390\/ijms140612222","volume":"14","author":"J D\u2019Orazio","year":"2013","unstructured":"D\u2019Orazio, J., Jarrett, S., Amaro-Ortiz, A. & Scott, T. UV radiation and the skin. Int. J. Mol. Sci. 14, 12222\u201312248 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"45034_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1039\/c5pp00098j","volume":"14","author":"B Ferguson","year":"2015","unstructured":"Ferguson, B., Kunisada, T., Aoki, H., Handoko, H. Y. & Walker, G. J. Hair follicle melanocyte precursors are awoken by ultraviolet radiation via a cell extrinsic mechanism. Photochem. Photobiol. Sci. 14, 1179\u20131189 (2015).","journal-title":"Photochem. Photobiol. Sci."},{"key":"45034_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/dvg.20205","volume":"44","author":"M Bosenberg","year":"2006","unstructured":"Bosenberg, M. et al. Characterization of melanocyte-specific inducible Cre recombinase transgenic mice. Genesis 44, 262\u2013267 (2006).","journal-title":"Genesis"},{"key":"45034_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"45034_CR30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1126\/science.1184733","volume":"327","author":"HJ Snippert","year":"2010","unstructured":"Snippert, H. J. et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science 327, 1385\u20131389 (2010).","journal-title":"Science"},{"key":"45034_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jdv.15348","volume":"33","author":"HW Higgins","year":"2019","unstructured":"Higgins, H. W. et al. Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study. J. Eur. Acad. Dermatol. Venereol. 33, 1268\u20131271 (2019).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"45034_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s40471-019-00192-7","volume":"6","author":"MR Schwartz","year":"2019","unstructured":"Schwartz, M. R., Luo, L. & Berwick, M. Sex differences in melanoma. Curr. Epidemiol. Rep. 6, 112\u2013118 (2019).","journal-title":"Curr. Epidemiol. Rep."},{"key":"45034_CR33","unstructured":"Incidence of Malignant Melanoma of the Skin\u2013United States, 2009\u20132018 | CDC. at https:\/\/www.cdc.gov\/cancer\/uscs\/about\/data-briefs\/no28-melanoma-2018.htm."},{"key":"45034_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2133.1988.tb01746.x","volume":"118","author":"JL Hawk","year":"1988","unstructured":"Hawk, J. L., Murphy, G. M. & Holden, C. A. The presence of neutrophils in human cutaneous ultraviolet-B inflammation. Br. J. Dermatol. 118, 27\u201330 (1988).","journal-title":"Br. J. Dermatol."},{"key":"45034_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2249.2007.03332.x","volume":"148","author":"I Endoh","year":"2007","unstructured":"Endoh, I. et al. Ultraviolet B irradiation selectively increases the production of interleukin-8 in human cord blood-derived mast cells. Clin. Exp. Immunol. 148, 161\u2013167 (2007).","journal-title":"Clin. Exp. Immunol."},{"key":"45034_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2302\/kjm.54.165","volume":"54","author":"T Schwarz","year":"2005","unstructured":"Schwarz, T. Mechanisms of UV-induced immunosuppression. Keio J. Med. 54, 165\u2013171 (2005).","journal-title":"Keio J. Med."},{"key":"45034_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2007.02.010","volume":"255","author":"SK Katiyar","year":"2007","unstructured":"Katiyar, S. K. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett. 255, 1\u201311 (2007).","journal-title":"Cancer Lett."},{"key":"45034_CR38","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fimmu.2019.01059","volume":"10","author":"AV Marzano","year":"2019","unstructured":"Marzano, A. V. et al. Mechanisms of inflammation in neutrophil-mediated skin diseases. Front. Immunol. 10, 1059 (2019).","journal-title":"Front. Immunol."},{"key":"45034_CR39","first-page":"20","volume":"3","author":"EC Davis","year":"2010","unstructured":"Davis, E. C. & Callender, V. D. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J. Clin. Aesthet. Dermatol. 3, 20\u201331 (2010).","journal-title":"J. Clin. Aesthet. Dermatol."},{"key":"45034_CR40","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/j.1365-2230.2011.04088.x","volume":"36","author":"V Vachiramon","year":"2011","unstructured":"Vachiramon, V. & Thadanipon, K. Postinflammatory hypopigmentation. Clin. Exp. Dermatol. 36, 708\u2013714 (2011).","journal-title":"Clin. Exp. Dermatol."},{"key":"45034_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature24271","volume":"550","author":"S Naik","year":"2017","unstructured":"Naik, S. et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550, 475\u2013480 (2017).","journal-title":"Nature"},{"key":"45034_CR42","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"45034_CR43","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jaad.2004.10.861","volume":"52","author":"T Brown","year":"2005","unstructured":"Brown, T., Zirvi, M., Cotsarelis, G. & Gelfand, J. M. Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts. J. Am. Acad. Dermatol. 52, 715\u2013716 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"45034_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-329","volume":"14","author":"W Li","year":"2014","unstructured":"Li, W., Xin, H., Ge, L., Song, H. & Cao, W. Induction of vitiligo after imiquimod treatment of condylomata acuminata. BMC Infect. Dis. 14, 329 (2014).","journal-title":"BMC Infect. Dis."},{"key":"45034_CR45","first-page":"466","volume":"101","author":"N Edgar","year":"2018","unstructured":"Edgar, N., Pilkington, S. & Hogan, D. J. Imiquimod-induced hypopigmentation following treatment of periungual verruca vulgaris. Cutis 101, 466\u2013468 (2018).","journal-title":"Cutis"},{"key":"45034_CR46","first-page":"74","volume":"33","author":"J Mashiah","year":"2008","unstructured":"Mashiah, J. & Brenner, S. Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod. Clin. Exp. Dermatol. 33, 74\u201376 (2008).","journal-title":"Clin. Exp. Dermatol."},{"key":"45034_CR47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","volume":"44","author":"TA Wynn","year":"2016","unstructured":"Wynn, T. A. & Vannella, K. M. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 44, 450\u2013462 (2016).","journal-title":"Immunity"},{"key":"45034_CR48","doi-asserted-by":"publisher","first-page":"eabl7482","DOI":"10.1126\/sciimmunol.abl7482","volume":"7","author":"DE Sanin","year":"2022","unstructured":"Sanin, D. E. et al. A common framework of monocyte-derived macrophage activation. Sci. Immunol. 7, eabl7482 (2022).","journal-title":"Sci. Immunol."},{"key":"45034_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"45034_CR50","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/ijms19061801","volume":"19","author":"C Atri","year":"2018","unstructured":"Atri, C., Guerfali, F. Z. & Laouini, D. Role of human macrophage polarization in inflammation during infectious diseases. Int. J. Mol. Sci. 19, 1801 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"45034_CR51","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.4049\/jimmunol.165.7.3985","volume":"165","author":"M Giroux","year":"2000","unstructured":"Giroux, M. & Descoteaux, A. Cyclooxygenase-2 expression in macrophages: modulation by protein kinase C-alpha. J. Immunol. 165, 3985\u20133991 (2000).","journal-title":"J. Immunol."},{"key":"45034_CR52","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/carcin\/19.5.723","volume":"19","author":"SY Buckman","year":"1998","unstructured":"Buckman, S. Y. et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19, 723\u2013729 (1998).","journal-title":"Carcinogenesis"},{"key":"45034_CR53","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1046\/j.1523-1747.2003.12495.x","volume":"121","author":"CS Tripp","year":"2003","unstructured":"Tripp, C. S. et al. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J. Investig. Dermatol. 121, 853\u2013861 (2003).","journal-title":"J. Investig. Dermatol."},{"key":"45034_CR54","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661\u2013665 (2007).","journal-title":"Nature"},{"key":"45034_CR55","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/gene.20192","volume":"44","author":"T-O Ishikawa","year":"2006","unstructured":"Ishikawa, T.-O. & Herschman, H. R. Conditional knockout mouse for tissue-specific disruption of the cyclooxygenase-2 (Cox-2) gene. Genesis 44, 143\u2013149 (2006).","journal-title":"Genesis"},{"key":"45034_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature10573","volume":"479","author":"A Van Keymeulen","year":"2011","unstructured":"Van Keymeulen, A. et al. Distinct stem cells contribute to mammary gland development and maintenance. Nature 479, 189\u2013193 (2011).","journal-title":"Nature"},{"key":"45034_CR57","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gni051","volume":"33","author":"G Belteki","year":"2005","unstructured":"Belteki, G. et al. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Res. 33, e51 (2005).","journal-title":"Nucleic Acids Res."},{"key":"45034_CR58","doi-asserted-by":"crossref","unstructured":"Averill, M. M., Kerkhoff, C. & Bornfeldt, K. E. S100A8 and S100A9 in cardiovascular biology and disease. Arterioscler. Thromb. Vasc. Biol. 32, 223\u2013229 (2012).","DOI":"10.1161\/ATVBAHA.111.236927"},{"key":"45034_CR59","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay, S. et al. Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell 162, 1257\u20131270 (2015).","journal-title":"Cell"},{"key":"45034_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-015-0260-7","volume":"15","author":"B Liu","year":"2015","unstructured":"Liu, B., Qu, L. & Yan, S. Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell Int. 15, 106 (2015).","journal-title":"Cancer Cell Int."},{"key":"45034_CR61","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","volume":"114","author":"V Prima","year":"2017","unstructured":"Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T. & Kusmartsev, S. COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proc. Natl. Acad. Sci. USA 114, 1117\u20131122 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"45034_CR62","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/oxfordjournals.jbchem.a132272","volume":"84","author":"H Ohno","year":"1978","unstructured":"Ohno, H., Morikawa, Y. & Hirata, F. Studies on 15-hydroxyprostaglandin dehydrogenase with various prostaglandin analogues. J. Biochem. 84, 1485\u20131494 (1978).","journal-title":"J. Biochem."},{"key":"45034_CR63","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","volume":"8","author":"W Goessling","year":"2011","unstructured":"Goessling, W. et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 8, 445\u2013458 (2011).","journal-title":"Cell Stem Cell"},{"key":"45034_CR64","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","volume":"136","author":"W Goessling","year":"2009","unstructured":"Goessling, W. et al. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136, 1136\u20131147 (2009).","journal-title":"Cell"},{"key":"45034_CR65","unstructured":"FDA approves topical treatment addressing repigmentation in vitiligo in patients aged 12 and older | FDA. at https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-topical-treatment-addressing-repigmentation-vitiligo-patients-aged-12-and-older."},{"key":"45034_CR66","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1016\/j.jid.2022.05.1093","volume":"142","author":"AG Pandya","year":"2022","unstructured":"Pandya, A. G. et al. Addition of narrow-band UVB phototherapy to ruxolitinib cream in patients with vitiligo. J. Investig. Dermatol. 142, 3352\u20133355.e4 (2022).","journal-title":"J. Investig. Dermatol."},{"key":"45034_CR67","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0002-9378(89)80020-1","volume":"160","author":"WF Rayburn","year":"1989","unstructured":"Rayburn, W. F. Prostaglandin E2 gel for cervical ripening and induction of labor: a critical analysis. Am. J. Obstet. Gynecol. 160, 529\u2013534 (1989).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"45034_CR68","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1046\/j.1365-4362.2002.01612.x","volume":"41","author":"D Parsad","year":"2002","unstructured":"Parsad, D., Pandhi, R., Dogra, S. & Kumar, B. Topical prostaglandin analog (PGE2) in vitiligo\u2013a preliminary study. Int. J. Dermatol. 41, 942\u2013945 (2002).","journal-title":"Int. J. Dermatol."},{"key":"45034_CR69","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2008.08923.x","volume":"160","author":"R Kapoor","year":"2009","unstructured":"Kapoor, R., Phiske, M. M. & Jerajani, H. R. Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo. Br. J. Dermatol. 160, 861\u2013863 (2009).","journal-title":"Br. J. Dermatol."},{"key":"45034_CR70","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41586-022-04833-8","volume":"606","author":"CP Vellano","year":"2022","unstructured":"Vellano, C. P. et al. Androgen receptor blockade promotes response to BRAF\/MEK-targeted therapy. Nature 606, 797\u2013803 (2022).","journal-title":"Nature"},{"key":"45034_CR71","doi-asserted-by":"crossref","unstructured":"Raising the bar on sex and gender reporting in research. Nat. Commun. 13, 2845 (2022).","DOI":"10.1038\/s41467-022-30398-1"},{"key":"45034_CR72","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.etap.2020.103512","volume":"81","author":"Q-Y Zhong","year":"2021","unstructured":"Zhong, Q.-Y. et al. Gender differences in UV-induced skin inflammation, skin carcinogenesis and systemic damage. Environ. Toxicol. Pharmacol. 81, 103512 (2021).","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"45034_CR73","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"45034_CR74","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","volume":"69","author":"WL Smith","year":"2000","unstructured":"Smith, W. L., DeWitt, D. L. & Garavito, R. M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69, 145\u2013182 (2000).","journal-title":"Annu. Rev. Biochem."},{"key":"45034_CR75","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/carcin\/bgs223","volume":"33","author":"K Dahlman-Wright","year":"2012","unstructured":"Dahlman-Wright, K. et al. Interplay between AP-1 and estrogen receptor \u03b1 in regulating gene expression and proliferation networks in breast cancer cells. Carcinogenesis 33, 1684\u20131691 (2012).","journal-title":"Carcinogenesis"},{"key":"45034_CR76","doi-asserted-by":"publisher","first-page":"637504","DOI":"10.3389\/fonc.2021.637504","volume":"11","author":"D Pu","year":"2021","unstructured":"Pu, D. et al. Cyclooxygenase-2 inhibitor: a potential combination strategy with immunotherapy in cancer. Front. Oncol. 11, 637504 (2021).","journal-title":"Front. Oncol."},{"key":"45034_CR77","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu, J., Zhang, X., Cheng, Y. & Cao, X. Dendritic cell migration in inflammation and immunity. Cell Mol. Immunol. 18, 2461\u20132471 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"45034_CR78","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41577-019-0162-3","volume":"19","author":"AW Ho","year":"2019","unstructured":"Ho, A. W. & Kupper, T. S. T cells and the skin: from protective immunity to inflammatory skin disorders. Nat. Rev. Immunol. 19, 490\u2013502 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"45034_CR79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0140-6736(91)92168-2","volume":"337","author":"JN Barker","year":"1991","unstructured":"Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M. & Nickoloff, B. J. Keratinocytes as initiators of inflammation. Lancet 337, 211\u2013214 (1991).","journal-title":"Lancet"},{"key":"45034_CR80","doi-asserted-by":"publisher","first-page":"e20221350","DOI":"10.1084\/jem.20221350","volume":"220","author":"KI Ko","year":"2023","unstructured":"Ko, K. I. et al. Distinct fibroblast progenitor subpopulation expedites regenerative mucosal healing by immunomodulation. J. Exp. Med. 220, e20221350 (2023).","journal-title":"J. Exp. Med."},{"key":"45034_CR81","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s40257-017-0298-5","volume":"18","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert, R. & van Geel, N. Vitiligo: an update on pathophysiology and treatment options. Am. J. Clin. Dermatol. 18, 733\u2013744 (2017).","journal-title":"Am. J. Clin. Dermatol."},{"key":"45034_CR82","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1023\/A:1008942828960","volume":"8","author":"BE Clausen","year":"1999","unstructured":"Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R. & F\u00f6rster, I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265\u2013277 (1999).","journal-title":"Transgenic Res."},{"key":"45034_CR83","doi-asserted-by":"publisher","first-page":"e95236","DOI":"10.1371\/journal.pone.0095236","volume":"9","author":"LE Dow","year":"2014","unstructured":"Dow, L. E. et al. Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice. PLoS One 9, e95236 (2014).","journal-title":"PLoS One"},{"key":"45034_CR84","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nmeth762","volume":"2","author":"T Buch","year":"2005","unstructured":"Buch, T. et al. A cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat. Methods 2, 419\u2013426 (2005).","journal-title":"Nat. Methods"},{"key":"45034_CR85","doi-asserted-by":"publisher","unstructured":"Moon, H., Donahue, L. R., Kim, D., An, L. & White, A. C. Spatial and temporal control of murine melanoma initiation from mutant melanocyte stem cells. J. Vis. Exp. https:\/\/doi.org\/10.3791\/59666 (2019).","DOI":"10.3791\/59666"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-45034-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-45034-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-45034-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T16:24:52Z","timestamp":1706631892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-45034-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,27]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["45034"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-45034-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.22.541644","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,27]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The corresponding author declares the following competing interests: Patent applicant: Cornell University. Name of the inventor: Andrew White. Application number: 63\/496,967. Status of application: Pending. Specific aspect of manuscript covered in patent application: Figure 7, use of pge2 analog with uvb and uvb+ruxolitinib. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"796"}}